About Cardiff Oncology (CRDF)
Cardiff Oncology Inc., formerly Trovagene, Inc., is a clinical-stage biotechnology company. The Company is focused on developing treatment options for cancer patients. It is developing onvansertib, a first-in-class, third-generation Polo-like Kinase ... Read more
- USD2.78
- USD2.92
- USD2.75
- USD5.64
- 2.10%
- 1M
- 11.00
- 814.21k
- 187M
- 2.01
- -19.80%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
